Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Apr 13, 2020 11:24am

157 Views

Post# 30903119

RE:RE:RE:RE:Rutherrin

Thanks for the reminder on TLD-1633 jiicoop.

Don`t want to muddy the waters here. Suggested Rutherrin as our most valuable asset in the belief that it is the most fully developed and understood but the issue is not 1433 vs 1633 or for that matter other compounds but rather the ability to pre-incubate them.

Do we have this or don`t we?

This question will have been proposed to HC in respect of Rutherrin some years` ago.

If TLT don`t have the ability to pre-incubate then why not and if they do then when do they intend to use it?

The degree to which the value of the Company depends on the answers to these questions cannot be overstated and there seems no valid reason why we cannot be told.

Bullboard Posts

Soma Gold poised to extend profitable track record